Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - cefazolin sodium, quantity: 0.524 g - injection, powder for - excipient ingredients: - treatment of the following serious infections due to susceptible organisms: - respiratory tract infections due to strep. pneumoniae, klebsiella sp., h. influenzae, staph. aureus (penicillin sensitive and penicillin resistant) and group a beta-haemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present; - genitourinary tract infections due to e. coli, p. mirabilis, klebsiella sp. and some strains of enterobacter and enterococci; - skin and skin structure infections due to staph. aureus (penicillin sensitive and penicillin resistant), and group a beta-haemolytic streptococci and other strains of streptococci; - bone and joint infections due to staph. aureus; - septicaemia due to strep. pneumoniae, staph. aureus (penicillin sensitive and penicillin resistant), p. mirabilis, e. coli and klebsiella sp.; - endocarditis due to staph. aureus (penicillin sensitive and penicillin resistant) and group a beta-haemolytic streptococci.,appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefazolin.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cefazolin sodium 1.048 g equivalent to 1 g cefazolin - powder for injection - 1 g - active: cefazolin sodium 1.048 g equivalent to 1 g cefazolin - cefazolin-aft is indicated in the treatment of the following serious infections due to susceptible organisms: respiratory tract infection: due to s. pneumoniae, klebsiella sp, h. influenzae, staph, aureus (including penicillinase-producing strains), and group a ?-haemolytic streptococci. injectable penicillin g benzathine is considered to be the medicine of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin-aft is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cephazolin in the subsequent prevention of rheumatic fever are not available at present.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cefazolin sodium 524mg equivalent to 500 mg cefazolin - powder for injection - 500 mg - active: cefazolin sodium 524mg equivalent to 500 mg cefazolin - cefazolin-aft is indicated in the treatment of the following serious infections due to susceptible organisms: respiratory tract infection: due to s. pneumoniae, klebsiella sp, h. influenzae, staph, aureus (including penicillinase-producing strains), and group a ?-haemolytic streptococci. injectable penicillin g benzathine is considered to be the medicine of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin-aft is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cephazolin in the subsequent prevention of rheumatic fever are not available at present.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

multichem nz limited - cefazolin sodium 1.048 g equivalent to cephazolin 1 g;   - powder for injection - 1 g - active: cefazolin sodium 1.048 g equivalent to cephazolin 1 g  

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

multichem nz limited - cefazolin sodium 2.096 g equivalent to cefazolin 2 g;   - powder for injection - 2 g - active: cefazolin sodium 2.096 g equivalent to cefazolin 2 g  

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

multichem nz limited - cefazolin sodium 524mg equivalent to cephazolin 500 mg;   - powder for injection - 500 mg - active: cefazolin sodium 524mg equivalent to cephazolin 500 mg  

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cefazolin sodium 2.097 g equivalent to 2 g cefazolin - powder for injection - 2 g - active: cefazolin sodium 2.097 g equivalent to 2 g cefazolin - cefazolin-aft is indicated in the treatment of the following serious infections due to susceptible organisms: respiratory tract infection: due to s. pneumoniae, klebsiella sp, h. influenzae, staph, aureus (including penicillinase-producing strains), and group a ?-haemolytic streptococci. injectable penicillin g benzathine is considered to be the medicine of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin-aft is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cephazolin in the subsequent prevention of rheumatic fever are not available at present.

İsrail - İngilizce - Ministry of Health

trima israel pharmaceutical products maabarot ltd - cefazolin as sodium - powder for solution for inj/inf - cefazolin as sodium 1 g/vial - cefazolin - treatment of serious infections caused by susceptible organisms and also perioperatively for prophylaxis. treatment respiratory tract: respiratory tract infections due to streptococcus pneumoniae (formerly diplococcus pneumoniae) klebsiella species, haemophilus influenzae, staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group a b - hemolytic streptococci. cefazolin is effective in the eradication of streptococci from the nasopharynx. however data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present.urinary tract: infections due to escherichia coli klebsiella species proteus mirabilis and some strains of enterobacter and enterococci.skin and skin structure: hemolytic beta infections due to staphylococcus aureus (penicillin-sensitive and penicillin-resistant) group a streptococci and other strains of streptococci. biliary tract: infections due to escherichia coli various strains of streptococci proteus mirabilis klebsiella species and staphylococcus aureus.bone and joint :infections due to staphylococcus aureus.genital infections (i.e. prostatitis epididymitis) due to escherichia coli proteus mirabilis klebsiella species and some strains of enterococci.septicemia due to streptococcus pneumoniae (formerly diplococcus pneumoniae) staphylococcus aureus (penicillin-sensitive and penicillin-resistant) proteus mirabilis escherichia coli and klebsiella species.endocarditis caused by staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group a beta-hemolytic streptococci. appropriate culture and susceptibility studies should be performed to determine the susceptibility of the causative organism to cefazolin.perioperative prophylaxis: the prophylactic administraton of cefazolin perioperatively (preoperatively intraoperatively and postoperatively) may reduce the incidence of certain postoperative infectons in patients undergoing surgical procedures (e.g. hysterectomy gastrointestinal surgery and transurethral prostatectomy) that are classified as contaminated or potentially contaminated. the perioperative use of cefazolin may also be effective in surgical patients in whom infection at the operative site would present a serious risk (e.g. open-heart surgery and prosthetic arthroplasty).

İsrail - İngilizce - Ministry of Health

a.l. medi-market ltd. - cefazolin as sodium - powder for solution for inj/inf - cefazolin as sodium 1 g/vial - cefazolin - treatment of serious infections caused by susceptible organisms and also perioperatively for prophylaxis. treatment respiratory tract: respiratory tract infections due to streptococcus pneumoniae (formerly diplococcus pneumoniae) klebsiella species haemophilus influenzae staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group a b - hemolytic streptococci. cefazolin is effective in the eradication of streptococci from the nasopharynx. however data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present. urinary tract: infections due to escherichia coli klebsiella species proteus mirabilis and some strains of enterobacter and enterococci. skin and skin structure: -hemolytic beta infections due to staphylococcus aureus (penicillin-sensitive and penicillin-resistant) group a streptococci and other strains of streptococci. biliary tract: infections due to escherichia coli various strains of streptococci proteus mirabilis klebsiella species and staphylococcus aureus. bone and joint :infections due to staphylococcus aureus. genital infections (i.e. prostatitis epididymitis) due to escherichia coli proteus mirabilis klebsiella species and some strains of enterococci.septicemia due to streptococcus pneumoniae (formerly diplococcus pneumoniae) staphylococcus aureus (penicillin-sensitive and penicillin-resistant) proteus mirabilis escherichia coli and klebsiella species.endocarditis caused by staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group a beta-hemolytic streptococci. appropriate culture and susceptibility studies should be performed to determine the susceptibility of the causative organism to cefazolin.perioperative prophylaxis: the prophylactic administraton of cefazolin perioperatively (preoperatively intraoperatively and postoperatively) may reduce the incidence of certain postoperative infectons in patients undergoing surgical procedures (e.g. hysterectomy gastrointestinal surgery and transurethral prostatectomy) that are classified as contaminated or potentially contaminated. the perioperative use of cefazolin may also be effective in surgical patients in whom infection at the operative site would present a serious risk (e.g. open-heart surgery and prosthetic arthroplasty)

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - cefazolin sodium, quantity: 2.097 mg - injection, powder for - excipient ingredients: - treatment of the following serious infections due to susceptible organisms: ? respiratory tract infections due to strep. pneumoniae, klebsiella sp., h. influenzae, staph. aureus (penicillin sensitive and penicillin resistant) and group a beta-haemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present. ? genitourinary tract infections due to e. coli, p. mirabilis, klebsiella sp. and some strains of enterobacter and enterococci. ? skin and skin structure infections due to staph. aureus (penicillin sensitive and penicillin resistant) and group a beta-haemolytic streptococci and other strains of streptococci. ? bone and joint infections due to staph. aureus. ? septicaemia due to strep. pneumoniae, staph. aureus (penicillin sensitive and penicillin resistant), p. mirabilis, e. coli and klebsiella sp. ? endocarditis due to staph. aureus (penicillin sensitive and penicillin resistant) and group a beta-haemolytic streptococci. ? appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefazolin